D-0050-2021 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0050-2021 was initiated by RemedyRepack Inc. on Oct 11, 2020 and is designated Class II. Reason for recall: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer) The recall status is terminated (terminated Feb 24, 2021). Affected quantity: 79/30 count blister cards.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2020
Initiation Date
Oct 11, 2020
Termination Date
Feb 24, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
79/30 count blister cards

Product description

Metformin Hydrochloride Extended Release 750 mg, 30 count blister cards, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA NDC 70518-2480-00

Reason for recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Distribution pattern

Product was distributed to one customer in PA.

Code information

Lot Numbers: J0423350-121219 exp. date 12/31/2020 J0434828-020320 exp. date 02/28/2021 J0442511-031220 exp. date 03/31/2021 J0448429-040920 exp. date 04/30/2021 J0472499-081020, J0472532-081020 exp. date 08/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0050-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0050-2021. Report a data issue: hello@regdatalab.com.